Structural basis of the GM2 gangliosidosis B variant

被引:14
|
作者
Matsuzawa, F
Aikawa, S
Sakuraba, H
Lan, HTN
Tanaka, A
Ohno, K
Sugimoto, Y
Ninomiya, H
Doi, H
机构
[1] Celestar Lexico Sci Inc, Mihama Ku, Chiba 2618501, Japan
[2] Tokyo Metropolitan Org Med Res, Tokyo Metropolitan Inst Med Sci, Dept Clin Genet, Bunkyo Ku, Tokyo 1138613, Japan
[3] Osaka City Univ, Grad Sch Med, Dept Pediat, Abeno Ku, Osaka 5458585, Japan
[4] Tottori Univ, Fac Med, Sch Life Sci, Dept Pediat Neurol, Yonago, Tottori 6830826, Japan
[5] Tottori Univ, Fac Med, Sch Life Sci, Dept Neurobiol, Yonago, Tottori 6830826, Japan
关键词
GM2; gangliosidosis; Tay-Sachs disease; beta-hexosaminidase; homology modeling; ganglioside;
D O I
10.1007/s10038-003-0082-7
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
To study the structural basis of the GM2 gangliosidosis B variant, we constructed the three-dimensional structures of the human beta-hexosaminidase alpha-subunit and the heterodimer of the alpha- and beta-subunits, Hex A, by homology modeling. The alpha-subunit is composed of two domains, domains I and II. Nine mutant models due to specific missense mutations were constructed as well and compared with the wild type to determine structural defects. These nine mutations were divided into five groups according to structural defects. R178H is deduced to affect the active site directly, because R178 is important for binding to the substrate. C458Y and W420C are predicted to cause drastic structural changes in the barrel structure carrying the active site pocket. R504C/H is deduced to introduce a disruption of an essential binding with D494 in the beta-subunit for dimerization. R499C/H, located in an extra-helix, is deduced to disrupt hydrogen bonds with domain I and the barrel. R170W and L484P are deduced to affect the interface between domains I and II, causing destabilization. The structural defects reflect the biochemical abnormalities of the disease.
引用
收藏
页码:582 / 589
页数:8
相关论文
共 50 条
  • [21] Neurological Progression in GM2 Gangliosidosis
    Eichler, F.
    Giannikopoulos, O.
    Swathe, S.
    Crawford, K.
    Tiffi, C.
    ANNALS OF NEUROLOGY, 2009, 66 : S116 - S116
  • [22] PATHOLOGY OF FELINE GM2 GANGLIOSIDOSIS
    CORK, LC
    MUNNELL, JF
    LORENZ, MD
    AMERICAN JOURNAL OF PATHOLOGY, 1978, 90 (03): : 723 - 734
  • [23] Mutation of the GM2 activator protein in a feline model of GM2 gangliosidosis
    Martin, DR
    Cox, NR
    Morrison, NE
    Kennamer, DM
    Peck, SL
    Dodson, AN
    Gentry, AS
    Griffin, B
    Rolsma, MD
    Baker, HJ
    ACTA NEUROPATHOLOGICA, 2005, 110 (05) : 443 - 450
  • [24] Mutation of the GM2 activator protein in a feline model of GM2 gangliosidosis
    Douglas R. Martin
    Nancy R. Cox
    Nancy E. Morrison
    David M. Kennamer
    Stephanie L. Peck
    Arlene N. Dodson
    Atoska S. Gentry
    Brenda Griffin
    Mark D. Rolsma
    Henry J. Baker
    Acta Neuropathologica, 2005, 110 : 443 - 450
  • [25] GM2 gangliosidosis AB variant - Clinical and biochemical studies of a Japanese patient
    Sakuraba, H
    Itoh, K
    Shimmoto, M
    Utsumi, K
    Kase, R
    Hashimoto, Y
    Ozawa, T
    Ohwada, Y
    Imataka, G
    Eguchi, M
    Furukawa, T
    Schepers, U
    Sandhoff, K
    NEUROLOGY, 1999, 52 (02) : 372 - 377
  • [26] A CYS138-TO-ARG SUBSTITUTION IN THE GM2 ACTIVATOR PROTEIN IS ASSOCIATED WITH THE AB VARIANT FORM OF GM2 GANGLIOSIDOSIS
    XIE, B
    WANG, W
    MAHURAN, DJ
    AMERICAN JOURNAL OF HUMAN GENETICS, 1992, 50 (05) : 1046 - 1052
  • [27] Accumulation of dermatan sulphate in brain of juvenile form of GM2 gangliosidosis variant B1
    Lemos, M
    Pinto, R
    Ribeiro, MG
    Sá Miranda, C
    EUROPEAN JOURNAL OF HUMAN GENETICS, 1998, 6 : 171 - 171
  • [28] GLYCOPROTEINS IN BRAIN-TISSUE OF O-VARIANT OF GM2 GANGLIOSIDOSIS
    BRUNNGRA.EG
    BROWN, BD
    ARO, A
    JOURNAL OF NEUROCHEMISTRY, 1974, 22 (01) : 125 - 128
  • [29] AB VARIANT GM2 GANGLIOSIDOSIS - CEREBROSPINAL-FLUID AND NEUROPATHOLOGIC CHARACTERISTICS
    KOTAGAL, S
    WENGER, DA
    ALCALA, H
    GOMEZ, C
    HORENSTEIN, S
    NEUROLOGY, 1986, 36 (03) : 438 - 440
  • [30] Rare Variant of GM2 Gangliosidosis through Activator-Protein Deficiency
    Brackmann, Florian
    Kehrer, Christiane
    Kustermann, Wibke
    Boehringer, Judith
    Kraegeloh-Mann, Ingeborg
    Trollmann, Regina
    NEUROPEDIATRICS, 2017, 48 (02) : 127 - 130